Precision Peptide Company Inc (BPC.CN) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-117.5%

-CA$0.06

vs CA$0.32 price

Levered DCF

-CA$0.08

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

8.01

Safe zone

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
P/E	-2.14×	-1.2×	-17.56×	-21.12×	-121.88×
P/B	10.48×	-2.19×	-210.88×	112.51×	17.35×
P/S	196×	98.58×	102.1×	41.01×	310.28×
EV / EBITDA	-4.07×	-1.18×	-17.79×	-27.77×	-118.67×
Gross margin	-139.1%	56.6%	-11.5%	7.1%	-98.2%
Operating margin	-4529.9%	-7545.5%	-575.4%	-154.8%	-432.0%
Net margin	-9104.3%	-8450.2%	-581.4%	-194.1%	-252.9%
Current ratio	3.32×	0.25×	0.53×	1.66×	10.97×
Debt / equity	0×	-0.03×	0×	0×	0×
Interest coverage	0×	0×	0×	-1.91×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Return on equity	-486.9%	187.3%	1200.7%	-532.6%	-14.1%
Return on invested capital	-242.3%	172.9%	1188.4%	-411.1%	-24.2%
Return on assets	-340.1%	-565.6%	-866.0%	-181.8%	-12.9%
Free cash flow yield	-23.9%	-36.5%	-3.4%	-3.0%	-2.8%
Earnings yield	-46.4%	-85.7%	-5.7%	-4.7%	-0.8%
Enterprise value	CA$8.8M	CA$1.1M	CA$29.1M	CA$23.7M	CA$20.4M
Net debt / EBITDA	0.44×	0.13×	0.03×	0.09×	4.69×
Cash conversion cycle (days)	-330	-33,222	-139	60	387